Related Experiment Video
Updated: May 12, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Without Electroencephalogram Abnormalities or Cerebrospinal Fluid
Akihiro Miyashita1, Kensuke Takaoka1,2, Jatinder Lachar3
1Department of Internal Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, USA.
Abstract:
N-methyl-D-aspartate (NMDA) receptor encephalitis is one of the autoimmune disorders characterized by neuropsychiatric symptoms, most commonly associated with ovarian teratoma. While detection of NMDA receptor antibody in cerebrospinal fluid (CSF) is the diagnostic standard, it is often limited by a delayed turnaround time. Abnormal electroencephalogram (EEG) findings and pleocytosis in CSF analysis are frequently observed, and computed tomography (CT) can aid in identifying an underlying ovarian teratoma. Here we report the case of a 36-year-old female who presented with acute psychosis, had a normal EEG and no CSF pleocytosis, and was later diagnosed with NMDA receptor encephalitis associated with a 7 mm ovarian teratoma. This case underscores the diagnostic challenges in the setting of a normal EEG and no CSF pleocytosis, which emphasizes the importance of NMDA receptor antibody testing in CSF for accurate diagnosis.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology